Janney Montgomery Scott LLC boosted its holdings in Colgate-Palmolive (NYSE:CL) by 14.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 197,236 shares of the company’s stock after acquiring an additional 24,876 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Colgate-Palmolive were worth $14,369,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Pacer Advisors Inc. lifted its position in shares of Colgate-Palmolive by 8.4% during the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after buying an additional 1,566 shares in the last quarter. Fiduciary Trust Co. lifted its position in shares of Colgate-Palmolive by 1.6% during the 2nd quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock worth $12,663,000 after buying an additional 2,758 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of Colgate-Palmolive by 10.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock worth $83,914,000 after buying an additional 105,878 shares in the last quarter. Pensionfund DSM Netherlands bought a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $4,225,000. Finally, Pictet & Cie Europe SA lifted its position in shares of Colgate-Palmolive by 5.5% during the 3rd quarter. Pictet & Cie Europe SA now owns 123,000 shares of the company’s stock worth $8,961,000 after buying an additional 6,400 shares in the last quarter. 73.10% of the stock is currently owned by institutional investors and hedge funds.
Several equities analysts have commented on CL shares. BNP Paribas cut shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 31st. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, October 17th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Finally, Jefferies Group decreased their price target on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research note on Monday, October 30th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and an average target price of $77.71.
Shares of Colgate-Palmolive (NYSE CL) traded up $0.79 during mid-day trading on Friday, hitting $69.76. 6,100,000 shares of the stock traded hands, compared to its average volume of 4,330,000. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. Colgate-Palmolive has a 12 month low of $66.47 and a 12 month high of $77.91. The stock has a market cap of $61,260.00, a price-to-earnings ratio of 30.60, a P/E/G ratio of 2.58 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same period in the previous year, the business earned $0.75 EPS. Colgate-Palmolive’s revenue was up 4.6% compared to the same quarter last year. equities research analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a $0.40 dividend. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.29%. Colgate-Palmolive’s dividend payout ratio is 70.18%.
In other news, Vice Chairman Franck J. Moison sold 142,979 shares of the business’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $70.09, for a total transaction of $10,021,398.11. Following the completion of the transaction, the insider now directly owns 224,027 shares in the company, valued at approximately $15,702,052.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Henning I. Jakobsen sold 36,215 shares of the business’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the transaction, the vice president now owns 70,783 shares of the company’s stock, valued at $5,041,165.26. The disclosure for this sale can be found here. Insiders sold a total of 327,451 shares of company stock valued at $23,534,707 over the last quarter. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.